Renovacor, Inc.
RCORDelisted Dec 1, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799850
Renovacor, Inc. was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Apr 5, 2023; 27 institutions reported holding it in 13F filings for Q3 2022, worth $18.4M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Renovacor, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +1 vs. Q3 2021
- Shares held
- 7.58M
- +391.4K (+5.4%) vs. Q3 2021
- Total value
- $58.4M
- −$6.15M (−9.5%) vs. Q3 2021
- New holders
- 5
- 5 more added
- Sold out
- 4
- 6 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RCOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 24 | $16.0M |
| Q1 2022 | 24 | $33.8M |
| Q4 2021 | 23 | $58.4M |
| Q3 2021 | 22 | $64.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Renovacor, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 64 | $0 | 0.00% | +64 | New |
| Royal Bank of Canada | 200 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 530 | $4.00K | 0.00% | +512+2,844.4% | Added |
| BlackRock Inc. | 617 | $5.00K | 0.00% | +617 | New |
| Wolverine Asset Management LLC | 930 | $7.00K | 0.00% | +930 | New |
| Tower Research Capital LLC (TRC) | 1,020 | $8.00K | 0.00% | +1,020 | New |
| Northern Trust Corp | 16,861 | $130.0K | 0.00% | +16,861 | New |
| D. E. Shaw & Co., Inc. | 25,321 | $195.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 33,897 | $261.0K | 0.01% | −9,885−22.6% | Reduced |
| Morgan Stanley | 53,035 | $408.0K | 0.00% | +1,848+3.6% | Added |
| Kepos Capital LP | 100,000 | $770.0K | 0.06% | 00.0% | Unchanged |
| HRT Financial LP | 117,314 | $903.0K | 0.01% | −8,382−6.7% | Reduced |
| Affinity Asset Advisors, LLC | 125,000 | $963.0K | 0.41% | +10,000+8.7% | Added |
| Pura Vida Investments, LLC | 150,505 | $1.16M | 0.12% | −1,574−1.0% | Reduced |
| 683 Capital Management, LLC | 175,000 | $1.35M | 0.06% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 342,902 | $2.64M | 0.76% | −100,000−22.6% | Reduced |
| Altium Capital Management LP | 388,845 | $2.99M | 0.84% | 00.0% | Unchanged |
| Vanguard Group Inc | 418,487 | $3.22M | 0.00% | +67,855+19.4% | Added |
| Cormorant Asset Management, LP | 500,000 | $3.85M | 0.23% | 00.0% | Unchanged |
| New Leaf Venture Partners, L.L.C. | 697,436 | $5.37M | 1.95% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 735,908 | $5.67M | 1.73% | −415−0.1% | Reduced |
| Citadel Advisors LLC | 1,052,624 | $8.11M | 0.01% | −1,809−0.2% | Reduced |
| RTW Investments, LP | 2,647,540 | $20.4M | 0.30% | +460,000+21.0% | Added |
| Murchinson Ltd. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,521−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −745−100.0% | Sold out |